Cite
HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study.
MLA
Bergqvist, Rita, et al. “HMG-CoA Reductase Inhibitors and COVID-19 Mortality in Stockholm, Sweden: A Registry-Based Cohort Study.” PLoS Medicine, vol. 18, no. 10, Oct. 2021, p. e1003820. EBSCOhost, https://doi.org/10.1371/journal.pmed.1003820.
APA
Bergqvist, R., Ahlqvist, V. H., Lundberg, M., Hergens, M.-P., Sundström, J., Bell, M., & Magnusson, C. (2021). HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study. PLoS Medicine, 18(10), e1003820. https://doi.org/10.1371/journal.pmed.1003820
Chicago
Bergqvist, Rita, Viktor H Ahlqvist, Michael Lundberg, Maria-Pia Hergens, Johan Sundström, Max Bell, and Cecilia Magnusson. 2021. “HMG-CoA Reductase Inhibitors and COVID-19 Mortality in Stockholm, Sweden: A Registry-Based Cohort Study.” PLoS Medicine 18 (10): e1003820. doi:10.1371/journal.pmed.1003820.